Free Trial

Inhibrx Biosciences (INBX) Earnings Date, Estimates & Call Transcripts

Inhibrx Biosciences logo
$14.50 -0.30 (-1.99%)
As of 03:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Inhibrx Biosciences Earnings Summary

Inhibrx Biosciences issued Q4 2024 earnings on May 14, 2025, reporting an EPS of -$2.80, which missed the consensus estimate of -$2.55 by $0.25. With a trailing EPS of $116.75 and a P/E Ratio of 0.13, Inhibrx Biosciences' earnings are expected to decrease next year, from $104.88 to ($12.08) per share.

Upcoming
Earnings Date
Aug. 12Before Market OpensEstimated
Consensus EPS
(May. 14)
-$2.55
Actual EPS
(May. 14)
-$2.80 Missed By -$0.25

Q4 2024 Earnings Resources

INBX Upcoming Earnings

Inhibrx Biosciences' next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules.

Get Inhibrx Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inhibrx Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

INBX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INBX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Inhibrx Biosciences Analyst EPS Estimates

Current Year EPS Consensus Estimate
$104.88 EPS
Next Year EPS Consensus Estimate
($12.08) EPS

Inhibrx Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2025
(Estimated)
--------
5/14/2025Q4 2024-$2.55-$2.80 -$0.25-$2.80--
3/17/2025Q4 2024-$2.88-$3.09 -$0.21-$3.09-$0.10M
8/13/2024Q2 2024-$3.60$125.48+$129.08$125.48-$0.10M
2/28/2024Q4 2023-$1.07-$1.73 -$0.66-$1.73$0.10M$1.63M
11/9/2023Q3 2023-$1.01-$1.10 -$0.09-$1.10-$0.12M
8/7/2023Q2 2023-$1.02-$1.08 -$0.06-$1.08-$0.03M

Inhibrx Biosciences Earnings - Frequently Asked Questions

Inhibrx Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on INBX's earnings history.

In the previous quarter, Inhibrx Biosciences (NASDAQ:INBX) missed the analysts' consensus estimate of ($2.55) by $0.25 with a reported earnings per share (EPS) of ($2.80). Learn more on analysts' earnings estimate vs. INBX's actual earnings.

Inhibrx Biosciences (NASDAQ:INBX) has a recorded annual revenue of $200,000.00.

Inhibrx Biosciences (NASDAQ:INBX) has a recorded net income of $1.69 billion. INBX has generated $116.75 earnings per share over the last four quarters.

Inhibrx Biosciences (NASDAQ:INBX) has a trailing price-to-earnings ratio of 0.13 and a forward price-to-earnings ratio of 0.14.

Inhibrx Biosciences' earnings are expected to decrease from $104.88 per share to ($12.08) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:INBX) was last updated on 6/27/2025 by MarketBeat.com Staff
From Our Partners